Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 22, 2021 - Issue 16: Pharmacotherapy for Diabetes and its complications
Submit an article Journal homepage
391
Views
2
CrossRef citations to date
0
Altmetric
Drug Evaluation

An evaluation of canagliflozin for the treatment of type 2 diabetes: an update

Taichi Minamia Department of Diabetes and Endocrinology, Saiseikai Yokohamashi Nanbu Hospital, Konan-ku, Yokohama, Japan;b Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University, Kanazawa-ku, Yokohama, JapanView further author information
,
Akiko Kamedaa Department of Diabetes and Endocrinology, Saiseikai Yokohamashi Nanbu Hospital, Konan-ku, Yokohama, JapanView further author information
&
Yasuo Terauchib Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University, Kanazawa-ku, Yokohama, JapanCorrespondence[email protected]
View further author information
Pages 2087-2094 | Received 29 Dec 2020, Accepted 03 Jun 2021, Published online: 11 Jun 2021

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shubham Batra, Prabhjeet Kaur Bamrah & Manjusha Choudhary. (2023) Sodium-glucose transporter (SGLT2) inhibition: A potential target for treatment of type-2 Diabetes Mellitus with Natural and Synthetic compounds. Egyptian Journal of Basic and Applied Sciences 10:1, pages 69-82.
Read now

Articles from other publishers (1)

Yang Pan, Yuting Luo, Jing Hong, Huacheng He, Lu Dai, Hong Zhu & Jiang Wu. (2022) Advances for the treatment of lower extremity arterial disease associated with diabetes mellitus. Frontiers in Molecular Biosciences 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.